These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

103 related items for PubMed ID: 7152076

  • 21. The effect of pentoxifylline on the deformability of erythrocytes and on the muscular oxygen pressure in patients with chronic arterial disease.
    Ehrly AM.
    J Med; 1979; 10(5):331-8. PubMed ID: 294470
    [No Abstract] [Full Text] [Related]

  • 22. [Doppler flowmeter evaluation of the effects of the administration of buflomedil (irrodan) on peripheral circulation in patients with obstructive chronic arteriopathy].
    Abate S, Ferulano GP, Vanni L, Dilillo S, Picilli M, D'Alessio E.
    Minerva Cardioangiol; 1985 Nov; 33(11):749-56. PubMed ID: 2935748
    [No Abstract] [Full Text] [Related]

  • 23. Effect of buflomedil on cell metabolism in ischemic muscle.
    Skau T, Aldman A, Lewis DH, Larsson J.
    Int Angiol; 1988 Nov; 7(4):337-43. PubMed ID: 3243989
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Buflomedil. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in peripheral and cerebral vascular diseases.
    Clissold SP, Lynch S, Sorkin EM.
    Drugs; 1987 May; 33(5):430-60. PubMed ID: 3297620
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Assessment of collateral perfusion: a pharmacodynamic study with buflomedil hydrochloride.
    Labs KH, Eichlisberger R, Jeanneret C, Frauchiger B, Aschwanden M, Jäger KA.
    Angiology; 2000 Apr; 51(4):301-8. PubMed ID: 10779000
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. [Effects of the administration of buflomedil-hydrochloride on the arterial circulation of the legs in patients with obliterative arteriopathies].
    Tallarida G, Baldoni F, Peruzzi G, Raimondi G, Grimaldi I, Visigalli G, Gristina S, Massaro M, De Martinis L, Sangiorgi M.
    Cardiologia; 1983 Aug; 28(8):651-60. PubMed ID: 6687209
    [No Abstract] [Full Text] [Related]

  • 33. [Exertion-induced metabolic changes in arterial occlusive diseases with different distances of painfree walking].
    Maass U, Grote R, Alexander K.
    Vasa; 1986 Aug; 15(3):206-11. PubMed ID: 3765795
    [No Abstract] [Full Text] [Related]

  • 34. Vasoactive effects of buflomedil assessed by fluorescein angiography.
    Platania A, Sciuto V, De Martino Rosaroll G.
    Curr Med Res Opin; 1987 Aug; 10(7):457-67. PubMed ID: 3621991
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Comparative evaluation of the effectiveness of buflomedil and pentoxifylline in patients with arterial occlusive disease.
    Trübestein G, Trübestein R, Duong QD.
    Angiology; 1981 Oct; 32(10):705-10. PubMed ID: 7034591
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 6.